AFP and neoplasm: In a cohort of 38 samples from 20 patients, QUENCH’s effectiveness in detecting CTNNB1 ctDNA was assessed and compared with ddPCR ctDNA and AFP levels, evaluating correlations with tumor burden and treatment response.